Plain-English translation of NCT05883072 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Researchers want to see if an AI chatbot — similar to ChatGPT — can help people with type 2 diabetes get better information about managing their condition. You would interact with the chatbot to ask questions about diet, stress, weight control, and diabetic complications. Doctors and specialists would then review how well the chatbot helped you and ask what you thought of the experience.
Type 2 diabetes affects hundreds of millions of people worldwide and can lead to serious complications like eye problems, foot ulcers, and kidney damage. Many of these complications can be prevented if patients have access to good information and support — and researchers want to test whether this AI tool can provide that kind of help.
You likely qualify if…
You likely don't qualify if…
You would have access to an AI chatbot that you can ask questions about managing your diabetes, diet, weight, and stress. The research team may provide support alongside the chatbot in some cases. After using the chatbot, specialists would review your interactions and ask you to share feedback about your experience with the tool.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Pakistan
Pakistan Council of Scientific and Industrial Research
Enrollment target
~300 participants
Started
January 2023
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in June 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ghulam Mustafa
Pakistan Council of Scientific and Industrial Research
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.